Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
Anna Kotronen(University of Helsinki), Hannele Yki‐Järvinen(University of Helsinki)
Cited by 804
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
|The Lancet Neurology|2011|420
Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling
|PLoS ONE|2020|385
Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease
|Journal of Hepatology|2021|280
Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes.
|Arteriosclerosis An Official Journal of the American Heart Association Inc|1988|187